GlassScriptPhysician profile
Karl D Bassler
NPI 1215938949
$1,914.14
in general payments reported to CMS, 2019-2025
20 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $35.02 · 2021: $175 · 2022: $226 · 2023: $201 · 2024: $503 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.97 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $309.82 | 2019-2025 | Adbry |
| Pfizer INC. | $295.79 | 2021-2023 | |
| Janssen Biotech, INC. | $231.39 | 2022-2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $198.72 | 2019-2021 | |
| Celgene Corporation | $137.09 | 2019 | |
| Abbvie INC. | $127.89 | 2019-2024 | |
| Galderma Laboratories, L.P. | $112.52 | 2024-2025 | Aklief |
| Sun Pharmaceutical Industries INC. | $75.07 | 2019-2024 | |
| Lilly USA, LLC | $65.54 | 2019 | |
| Amgen INC. | $58.06 | 2023-2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $55.87 | 2023-2024 | Zoryve |
| Urgo Medical North America, LLC | $53.34 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Incyte Corporation | $40.87 | 2022-2024 | Opzelura |
| Ucb, INC. | $38.99 | 2024 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $27.11 | 2025 | Libtayo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $24.04 | 2025 | Klisyri |
| Sanofi-Aventis U.S. LLC | $21.61 | 2021 | |
| Genzyme Corporation | $20.28 | 2022 | |
| Botanix Sb INC | $17.23 | 2025 | Sofdra |
| Prugen, INC. Pharmaceuticals | $2.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Bassler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.